• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Ultrasound Aids in Management of Elbow Injuries

Article

Point-of-care ultrasound, instead of CT, effective in diagnosis and management of elbow injuries.

Point-of-care ultrasound (POCUS) is effective in the diagnosis and management of elbow fractures when direct radiology is inconclusive and CT is required, according to a study published in The American Journal of Emergency Medicine.

Researchers from Turkey sought to compare the efficiency of POCUS compared with CT for patients presenting with elbow injuries for both diagnosis and management of the fracture.

Forty-nine patients who presented with low energy elbow injuries and at least one fracture of the elbow participated in the study. Patient age ranged from five to 65, with a mean age 21. Sixty-three percent of all patients were male. All patients underwent direct radiology, followed by both ultrasound and CT. Emergency room physicians made treatment decisions based on the POCUS findings. The CT scans were then performed. Orthopedic surgeons made treatment decisions based on the CT results, interpreted by radiologists.

The results showed that compared with CT, POCUS was a valid method of imaging for fracture detection in elbow injuries:

 
POCUS
Sensitivity
97%
Specificity
88%
Positive predictive value
94%
Negative predictive value
93%

 

 

 

 

In addition, while the sensitivity and specificity of POCUS in the decision for reduction was 95% and 100%, respectively, it was 93% and 100% in the decision for surgery.

“POCUS was shown to be successfully applied in the diagnosis and management of elbow injuries in which DR was inefficient and CT scans were required,” the researchers concluded.

Related Videos
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Nina Kottler, MD, MS
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Related Content
© 2024 MJH Life Sciences

All rights reserved.